Glutaryl-L-alanyl-L-alanyl-L-phenylalanine 4-methylcoumaryl-7-amide

<strong>Glutaryl-L-alanyl-L-alanyl-L-phenylalanine 4-methylcoumaryl-7-amide</strong> <strong>Catalog number:</strong> MDP0203 <strong>CAS Number: </strong>1042405-14-0 <strong>Sequence: </strong>Glutaryl-L-alanyl-L-alanyl-L-phenylalanine 4-methylcoumaryl-7-amide <strong>Amount:</strong> 1 mg <strong>Molecular Weight:</strong> 578.4 g/mol <strong>Supplied as:</strong> Powder <strong>Applications:</strong> molecular tool for various biochemical applications <strong>Storage:</strong> -20 °C <strong>WARNING:</strong> For in vitro Research Use Only. NOT for use on humans or animals. <strong>Grade:</strong> Biotechnology grade. All products are highly pure. <strong>References:</strong> 1: Hayasaka K, Ikeda H. [Glutaryl-CoA dehydrogenase deficiency (glutaric aciduria type I)] Ryoikibetsu Shokogun Shirizu. 1998;(18 Pt 1):332-5. 2: Goodman SI, Stein DE, Schlesinger S, Christensen E, Schwartz M, Greenberg CR, Elpeleg ON. Glutaryl-CoA dehydrogenase mutations in glutaric acidemia (type I): review and report of thirty novel mutations Hum Mutat. 1998;12(3):141-4. 3: McClelland VM, Gissen P, Hendriksz C, Chakrapani A. Glutaryl-CoA dehydrogenase deficiency Pediatr Res. 2007 Jan;61(1):134; author reply 134-5. 4: Damrongrungruang T, Panpitakkul P, Somudorn J, Sangchart P, Mahakunakorn P, Uthaiwat P, Daduang J, Panyatip P, Puthongking P, Priprem A. Glutaryl Melatonin Niosome Gel for Topical Oral Mucositis: Anti- Inflammatory and Anticandidiasis Curr Drug Deliv. 2020;17(3):195-206. 5: Larson A, Goodman S. Glutaric Acidemia Type 1 2019 Sep 19. In: Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2023. 6: Bhatt DP, Mills CA, Anderson KA, Henriques BJ, Lucas TG, Francisco S, Liu J, Ilkayeva OR, Adams AE, Kulkarni SR, Backos DS, Major MB, Grimsrud PA, Gomes CM, Hirschey MD. Deglutarylation of glutaryl-CoA dehydrogenase by deacylating enzyme SIRT5 promotes lysine oxidation in mice J Biol Chem. 2022 Apr;298(4):101723. 7: Mühlhausen C, Hoffmann GF, Strauss KA, Kölker S, Okun JG, Greenberg CR, Naughten ER, Ullrich K. Maintenance treatment of glutaryl-CoA dehydrogenase deficiency J Inherit Metab Dis. 2004;27(6):885-92. 8: Kölker S, Greenberg CR, Lindner M, Müller E, Naughten ER, Hoffmann GF. Emergency treatment in glutaryl-CoA dehydrogenase deficiency J Inherit Metab Dis. 2004;27(6):893-902. 9: Lindner M, Kölker S, Schulze A, Christensen E, Greenberg CR, Hoffmann GF. Neonatal screening for glutaryl-CoA dehydrogenase deficiency J Inherit Metab Dis. 2004;27(6):851-9. <a href="https://pubmed.ncbi.nlm.nih.gov/24729724">10: Gomez SI, Mihos CG, Pineda AM, Santana O. The pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in renal disease Int J Nephrol Renovasc Dis. 2014 Mar 28;7:123-30. </a> <br><strong>Products Related to Glutaryl-L-alanyl-L-alanyl-L-phenylalanine 4-methylcoumaryl-7-amide can be found at</strong> <a href="https://moleculardepot.com/product-category/Peptides/"> Peptides</a>